These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 25203778
1. Discovery of small molecular inhibitors targeting HIV-1 gp120-CD4 interaction drived from BMS-378806. Liu T, Huang B, Zhan P, De Clercq E, Liu X. Eur J Med Chem; 2014 Oct 30; 86():481-90. PubMed ID: 25203778 [Abstract] [Full Text] [Related]
2. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120. Schön A, Madani N, Klein JC, Hubicki A, Ng D, Yang X, Smith AB, Sodroski J, Freire E. Biochemistry; 2006 Sep 12; 45(36):10973-80. PubMed ID: 16953583 [Abstract] [Full Text] [Related]
3. Molecular docking guided structure based design of symmetrical N,N'-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors. Sivan SK, Vangala R, Manga V. Bioorg Med Chem; 2013 Aug 01; 21(15):4591-9. PubMed ID: 23777826 [Abstract] [Full Text] [Related]
4. Understanding the binding mode and function of BMS-488043 against HIV-1 viral entry. Da LT, Quan JM, Wu YD. Proteins; 2011 Jun 01; 79(6):1810-9. PubMed ID: 21465559 [Abstract] [Full Text] [Related]
5. Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors. Ohashi N, Harada S, Mizuguchi T, Irahara Y, Yamada Y, Kotani M, Nomura W, Matsushita S, Yoshimura K, Tamamura H. ChemMedChem; 2016 Apr 19; 11(8):940-6. PubMed ID: 26891461 [Abstract] [Full Text] [Related]
6. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors. Teixeira C, Serradji N, Maurel F, Barbault F. Eur J Med Chem; 2009 Sep 19; 44(9):3524-32. PubMed ID: 19410340 [Abstract] [Full Text] [Related]
7. Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events. Ho HT, Fan L, Nowicka-Sans B, McAuliffe B, Li CB, Yamanaka G, Zhou N, Fang H, Dicker I, Dalterio R, Gong YF, Wang T, Yin Z, Ueda Y, Matiskella J, Kadow J, Clapham P, Robinson J, Colonno R, Lin PF. J Virol; 2006 Apr 19; 80(8):4017-25. PubMed ID: 16571818 [Abstract] [Full Text] [Related]
9. Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction. Williams DH, Adam F, Fenwick DR, Fok-Seang J, Gardner I, Hay D, Jaiessh R, Middleton DS, Mowbray CE, Parkinson T, Perros M, Pickford C, Platts M, Randall A, Siddle D, Stephenson PT, Tran TD, Vuong H. Bioorg Med Chem Lett; 2009 Sep 01; 19(17):5246-9. PubMed ID: 19620004 [Abstract] [Full Text] [Related]
13. Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action. Langley DR, Kimura SR, Sivaprakasam P, Zhou N, Dicker I, McAuliffe B, Wang T, Kadow JF, Meanwell NA, Krystal M. Proteins; 2015 Feb 01; 83(2):331-50. PubMed ID: 25401969 [Abstract] [Full Text] [Related]
14. Localized changes in the gp120 envelope glycoprotein confer resistance to human immunodeficiency virus entry inhibitors BMS-806 and #155. Madani N, Perdigoto AL, Srinivasan K, Cox JM, Chruma JJ, LaLonde J, Head M, Smith AB, Sodroski JG. J Virol; 2004 Apr 01; 78(7):3742-52. PubMed ID: 15016894 [Abstract] [Full Text] [Related]
16. Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist. Courter JR, Madani N, Sodroski J, Schön A, Freire E, Kwong PD, Hendrickson WA, Chaiken IM, LaLonde JM, Smith AB. Acc Chem Res; 2014 Apr 15; 47(4):1228-37. PubMed ID: 24502450 [Abstract] [Full Text] [Related]